In a case-control study of NAFLD patients, increased hepatic methylation of the promoter of the PPARγ coactivator one-alpha (PGC1-α) gene, a key transcriptional regulator of mitochondrial fatty acid oxidation, significantly correlated with peripheral IR status and fasting insulin levels [43]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.